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We studied the effects of long-lasting treating with cadmium in two different doses (0.1 and 1.0 μg/kg) 
on the activity of matrix metalloproteinases (MMP2 and MMP9) and metallothionein level in the rat 
brain. Cadmium in a higher dose (1 μg/kg) caused a decrease in MMP2 activity but increased that of 
proMMP9 in the brain. The level of MT in the hippocampus and cerebellum dropped with both Cd doses. 
Thus, even small Cd doses exert specific effects on the MMP activity and MT level in the brain.
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INTRODUCTION
Among the exogenous risk factors for the 
development of neurodegenerative diseases, special 
attention should be paid to cadmium (Cd), a metal 
widely used in the industrial production of alloys and 
pigments and in the electrical industry. Cadmium 
in the air may appear as by-products of smelting 
lead and zinc, due to burning of plastics, and due 
to disruption related to utilization of cadmium-
nickel batteries. The intake of Cd in the body is also 
possible with cigarette smoke and with food; blood 
absorbs up to 40-50% Cd entering by inhalation 
and up to 3-7% when eating [1]. The effect of Cd 
is long-lasting, as it is slowly excreted from the 
body. The Cd half-life in the liver is 19 years, and 
in the kidneys it is 38 years. This heavy metal 
can be accumulated in bones, kidneys, pancreatic 
and prostatic glands, testicles, and placenta [2]. 
A growth in its content in tissues can lead to the 
development of renal failure and emphysema; it 
increases the risk for coronary insufficiency, cancer, 
and neurodegenerative diseases. 
Cadmium can substitute zinc and copper atoms 
in metal-containing enzymes and proteins. Such 
substitution leads to inhibition of the activity of 
the latter and the development of pathological 
conditions. However, the effect of Cd on the activity 
of Zn2+-containing matrix metalloproteinases 
(MMPs) and metallothioneins (MTs) has practically 
not been investigated. Many pathological processes 
are associated with the disturbance of MMP activity; 
these are oncogenesis, atherosclerosis, and tissue 
fibrosis. These enzymes are involved not only in 
degradation of the intercellular matrix, but also 
in the processes of cell growth and migration, 
regulation of signaling pathways, formation 
of the endothelium, and that of atherosclerotic 
plaques. Gelatinases A (MMP2) and B (MMP9) 
are characterized by a broad substrate specificity 
and play an important role in the development of 
cardiovascular and neurodegenerative diseases.
Metal-binding metallothioneins are found in a 
vast population of organisms. These proteins are 
very rich in cysteine residues and do not manifest 
enzymatic activity [3]. 
The aim of our work was to estimate the effects of 
relatively low doses of Cd on the activity of MMP2 
and MMP9 and on the metallothionein level in the 
rat brain.
METHODS
Eighteen Wistar rats (6 month old, weighing 
190-200 g) were randomly divided into three groups 
(n = 6 in each). These were group 1 (control animals 
kept under standard conditions on a standard diet), 
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group 2 (rats given a cadmium-containing diet, 
0.1 μg/kg body mass), and group 3 (animals given 
a diet with a greater content of cadmium, 1.0 μg/
kg body mass). Highly-purified CdCl2∙2.5 H2O 
(Sigma, USA) and drinking water for babies 
containing no cadmium ions (solvent) were used for 
preparation of the cadmium solution. The latter was 
introduced perorally to the rats once a day before 
feeding. Water and food were freely available. 
The experiment lasted 37 days. At the end of the 
experiment, the animals were decapitated under 
thiopental anesthesia. The fraction containing water-
soluble proteins was obtained by ultracentrifugation. 
The initial buffer contained 0.25 mM Tris (pH 7.4), 
1.0 mM EDTA, 2.0 mM dithiothreitol, 0.2 mM 
phenylmethylsulfonyl fluoride (PMSF), and 3 mM 
sodium azide (NaN3) (Sigma, USA). 
Activities of gelatinases A and B (MMP2 and 
MMP9, respectively) were estimated using direct 
enzyme zymography after vertical electrophoresis of 
the samples in 7.5% PAG containing 0.1% SDS and 
1% gelatine (Sigma, USA). The zymograms were 
digitized, and gelatinase activity was calculated 
using Videodensitometer Sorbfil 2.0 software. 
This activity was measured in arbitrary units (a.u.) 
relative to the respective activities in a standard 
sample taken as 1.0 a.u. Protein concentrations in 
brain tissues were measured using the Bradford 
method. The specific activity of the studied enzymes 
was calculated per 1 mg of protein.
The metallothionein contents in the hippocampus 
and cerebellum were measured by ELISA using 
a monospecific antibody to MT (Santa Cruz 
Biotechnology, USA).
Statistical processing of the numerical data 
was performed using Microsoft® Excel 2000 
(Microsoft®) and STATISTICA® for Windows 6.0 
(StatSoft Inc., USA). Intergroup differences were 
evaluated by the Student t-test and Mann–Whitney 
criterion for small samplings; values with P ≤ 0.05 
were considered significant.
RESULTS AND DISCUSSION
The relative activity of gelatinases in the fraction 
of soluble brain proteins from rats treated for a long 
time with cadmium at a dose of 0.1 μg/kg remained 
practically unchanged. At the same time, in rats 
receiving higher doses of cadmium (1.0 μg/kg), the 
activity of proMMP9 increased to 22.4 ± 2.8 a.u./mg 
total protein (TP) in comparison with 17.9 ± 
± 0.8 a.u./mg TP. There were parallel decreases in 
the latent and mature forms of MMP2 to 12.7 ± 1.0 
and 13.4 ± 1.5 a.u./mg TP, respectively (values in the 
control group were 18.1 ± 0.9 and 17.8 ± 0.7 a.u./mg 
TP; Fig. 1).
The MT level in the hippocampus was found to 
drop significantly (to 72% in the 0.1 µg Cd group 
and to 58% in the 1.0 µg Cd group, as compared 
to the control). The same trend was found in the 
cerebellum, but the decrements were smaller than in 
the hippocampus (Fig. 2).
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F i g. 1. Relative average activities of gelatinases (a.u./mg total 
protein) in the fraction of soluble brain proteins. 1) Control group 
of the animals kept under standard conditions, 2 and 3) animals 
obtaining a cadmium-containing diet, 0.1 and 1.0 μg/kg body 
mass, respectively; n = 6 in all groups, *P < 0.05, **P < 0.01 in 
comparison with the control group; #P < 0.05 (in comparison the 
2nd and 3rd groups.
F i g. 2. The level of metallothionein, µg/g of tissue, in the rat 
brain (A – hippocampus, B – cerebellum) under conditions of Cd 
intoxication. Designations are similar to those in Fig 1.
